Spirair’s Post

Vision Care Market Trends 2025 to 2033 Vision Care market is expected to reach US$ 117.75 billion by 2033 from US$ 77.55 billion in 2024, with a CAGR of 4.75% from 2025 to 2033. Some of the key reasons driving the market are the ease and improvement of access to healthcare services, the expanding awareness campaign to educate people about the significance of eye health, and new technological developments in contact lenses, eyeglass frames, and lens materials. Read More: https://lnkd.in/gfjzBqPq The report Vision Care Market & Forecast covers by Product Type (Glass Lenses, Contact Lenses, Intraocular Lenses, Contact Solutions, Lasik Equipment, Artificial Tears), Treatment (Laser Therapy, Surgery, Medication), Distribution Channel (Retail Stores, E-Commerce, Clinics, Hospitals, Others), Countries and Company Analysis 2025-2033. #Vision_Care_Market #Vision_Care_Market_Trends

𝗛𝗗 𝗟𝗮𝗽𝗮𝗿𝗼𝘀𝗰𝗼𝗽𝘆 𝗠𝗮𝗿𝗸𝗲𝘁 𝟮𝟬𝟮𝟱-𝟮𝟬𝟯𝟭. 𝗚𝗹𝗼𝗯𝗮𝗹 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝗥𝗲𝗽𝗼𝗿𝘁 *𝗥𝗲𝗾𝘂𝗲𝘀𝘁 𝗳𝗼𝗿 𝗥𝗲𝗽𝗼𝗿𝘁 𝗦𝗮𝗺𝗽𝗹𝗲 𝗣𝗗𝗙: https://lnkd.in/dh563QAS The report provides a comprehensive overview of the HD Laparoscopy industry, detailing its development, market status across hospitals and clinics for both flexible and rigid laparoscopes, and profiling key enterprises in developed and emerging markets. It examines cutting-edge technologies, patents, applications, and market trends, with regional analysis highlighting steady growth in North America and Europe, driven by government initiatives and rising consumer awareness. Asia-Pacific, led by China, dominates the global market due to strong domestic demand, supportive policies, and a robust manufacturing base. The report offers a holistic view of the industry, analyzing market dynamics, trends, challenges, and opportunities, while delivering detailed insights into individual components and stakeholders. *𝗕𝘆 𝗧𝘆𝗽𝗲: Flexible Laparoscope, Rigid Laparoscope *𝗕𝘆 𝗔𝗽𝗽𝗹𝗶𝗰𝗮𝘁𝗶𝗼𝗻: Hospital, Clinic, Others *𝗕𝘆 𝗥𝗲𝗴𝗶𝗼𝗻: North America, Europe, Asia-Pacific, South America, Middle East & Africa *𝗕𝘆 𝗞𝗲𝘆 𝗣𝗹𝗮𝘆𝗲𝗿𝘀: Medtronic, Olympus Corporation, PENTAX Medical, FUJIFILM France (Medical Systems), Stryker, Mindray, Aesculap (US), Arthrex, Richard Wolf GmbH, Smith+Nephew #HDLaparoscopy #LaparoscopicSurgery #FlexibleLaparoscope #RigidLaparoscope #MinimallyInvasiveSurgery #SurgicalInnovation #MedicalDevices #AdvancedSurgery #LaparoscopyMarket #HospitalTechnology #ClinicSurgicalTools #EndoscopicTechnology #SurgicalImaging #HealthcareInnovation #LaparoscopyTrends #AsiaPacificLaparoscopy #SurgicalPatents #GlobalLaparoscopyMarket #LaparoscopyManufacturing #SurgicalTechAdvancements

💡 What sets us apart: •Clinician-Driven Design: Our devices are created in close collaboration with top surgeons, ensuring that functionality aligns with the demands of real-world applications. •Evidence-Based Innovation: Spectrum Spine prioritizes technologies that have been rigorously validated in clinical and preclinical settings to enhance predictability and trust. •Focused on Patient-Centered Outcomes: From reducing inflammation to minimizing revision rates, our implants aim to improve the metrics that matter most to surgeons and their patients. We’re not just innovating—we’re solving problems that others overlook. 👉 Learn more about our surgeon-focused approach at spectrumspine.com. #orthopedicexcellence #surgeoninnovation #spectrumspine #clinicalprecision

Join Mr. Gokulan Ratnarajan (UK) and Dr. Karsten Klabe (Germany) as they share their experiences with iSTAR Medical’s MINIject®. They discuss its role in glaucoma treatment, surgical approaches, IOP reduction goals, and why surgeons should consider adding MINIject® to their repertoire. Watch now for their expert insights—and for more on MINIject®, visit iSTAR Medical. #iSTARMedical #MINIject #MIGS #MediaMICE

𝐎𝐜𝐮𝐥𝐚𝐫 𝐈𝐦𝐩𝐥𝐚𝐧𝐭𝐬 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐨𝐧 𝐓𝐫𝐚𝐜𝐤 𝐟𝐨𝐫 $𝟐𝟑.𝟒𝟑 𝐁𝐢𝐥𝐥𝐢𝐨𝐧 𝐆𝐫𝐨𝐰𝐭𝐡 𝐛𝐲 𝟐𝟎𝟑𝟏 » 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/e8sfqTVw According to the latest publication by Meticulous Research®, the global #ocular_implant_market is poised to grow significantly, reaching $23.43 billion by 2031 with a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031. This growth is attributed to several factors, including the aging global population and the increasing prevalence of eye-related diseases. Additionally, the rising adoption of minimally invasive surgical techniques, coupled with advancements in healthcare infrastructure and technology, is boosting demand for ocular implants. Technological progress, including innovations in biomaterials and AI-driven solutions like #3D_printed_prosthetic_eyes, is reshaping the market landscape. The growing number of accidents requiring ocular interventions further drives market growth. However, several factors constrain this growth, such as risks of post-operative complications, a shortage of skilled ophthalmologists, and the stringent regulatory framework governing the approval of medical devices. » 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Alcon, Bausch + Lomb, ZEISS Group, Johnson & Johnson, STAAR Surgical, MORCHER GmbH, Hoya, Glaukos Corporation , AbbVie, Vivani.   » 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 : • 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/dV2HS5Xx • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/d4tRZYXH   #OcularImplants #VisionTechnology #EyeCareInnovation #MedicalDevices #VisionRestoration #RetinalImplants #EyeHealth #FutureOfVision #SightSolutions #Ophthalmology #EyeSurgeryTech #SmartImplants #VisionRecovery #NextGenHealthcare #BionicEye #EyeImplantResearch #VisionInnovation #SightForAll #MedicalTech #OcularTechMarket

Gynecologists👩🏼⚕️👨🏻⚕️ enhance your resectoscopy procedures ⁉️ The game-changer for hysteroscopic resection. Whether you are addressing #myomas, #polyps, or retained products of #conception Delmont Imaging introduces the Innovative Chips Extractor (ICE); Designed in close collaboration with the renowned Prof. FERNANDEZ HERVE MARC The ICE device is specifically engineered to optimize #hysteroscopic #resection procedures. By addressing the common challenges faced by #gynecologists during #resectoscopy, this advanced chips extractor elevates surgical performance and improves outcomes for both patients and practitioners. ICE simplifies the extraction of liquid, tissue chips, and blood clots, ensuring a clear operative field throughout the procedure. This feature enhances visibility, allowing surgeons to work with greater precision and confidence. It also eliminates the need for #cervical laceration, significantly reducing the risk of complications. This ensures safer, less invasive procedures and faster recovery for patients. The device seamlessly integrates into existing surgical workflows, offering intuitive operation and reduced procedural times. Thank you Pierre MONTILLOT and team Delmont Imaging for our great partnership ! Interested: contact Delmont Imaging Creanova - Create & Innovate Healthcare solutions for a better quality of life #DesignDevelopment #ContractManufacturing #CMO #MedicalDevices #gynecologist Caetano Lobo Sara Galfrascoli Valentina Sturniolo Stefano Robbiani Giovan Battista Basile Miloš Maričić Mattia Cattaneo Davide Quagliani Camiel Schijvens Laura Tagliabue Matteo Moroni Nevena Krstajic Andrea Menoncello Rohit Rana

#ISASS24 was filled with exciting content... Topics included advancements in spinal endoscopy, enabling technologies in the operating room, and long-term clinical outcomes in disc arthroplasty. I had the privilege of presenting the early results on the efficacy of personalized interbody implants in achieving target segmental lordosis. ✅ The target segmental lordosis was achieved (within 1.0° ± 4.2°) in 87.6% of levels. ✅ LLIF implants achieved the highest percentage of accuracy (90.5%). ✅ When target was missed by over 5°, the ALIF and LLIF implants were found to over-correct while the TLIF implant resulted in under-correction. 🎯 Patient-specific implants (compared to stock impants) are far more effective in achieving predictable and desired post operative segmental lordosis while avoiding under- or over-correction. #patientspecificimplant #ai #machinelearning AdventHealth Central Florida AdventHealthMD #personalizedmedicine Carlsmed

𝐕𝐢𝐬𝐢𝐨𝐧 𝐑𝐞𝐬𝐭𝐨𝐫𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧: 𝐄𝐱𝐩𝐥𝐨𝐫𝐢𝐧𝐠 𝐁𝐫𝐞𝐚𝐤𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐎𝐜𝐮𝐥𝐚𝐫 𝐈𝐦𝐩𝐥𝐚𝐧𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 » 𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 : https://lnkd.in/ec6zgpTA According to the latest publication by Meticulous Research®, the global #ocular_implant_market is poised to grow significantly, reaching $23.43 billion by 2031 with a compound annual growth rate (CAGR) of 6.1% from 2024 to 2031. This growth is attributed to several factors, including the aging global population and the increasing prevalence of eye-related diseases. Additionally, the rising adoption of minimally invasive surgical techniques, coupled with advancements in healthcare infrastructure and technology, is boosting demand for ocular implants. Technological progress, including innovations in biomaterials and AI-driven solutions like #3D_printed_prosthetic_eyes, is reshaping the market landscape. The growing number of accidents requiring ocular interventions further drives market growth. However, several factors constrain this growth, such as risks of post-operative complications, a shortage of skilled ophthalmologists, and the stringent regulatory framework governing the approval of medical devices. » 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 : Alcon, Bausch + Lomb, ZEISS Group, Johnson & Johnson, STAAR Surgical, MORCHER GmbH, Hoya, Glaukos Corporation , AbbVie, Vivani.   » 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 : • 𝗩𝗲𝘁𝗲𝗿𝗶𝗻𝗮𝗿𝘆 𝗩𝗮𝗰𝗰𝗶𝗻𝗲𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/dV2HS5Xx • 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗧𝗿𝗶𝗮𝗹𝘀 𝗠𝗮𝗿𝗸𝗲𝘁 : https://lnkd.in/d4tRZYXH   #OcularImplants #VisionTechnology #EyeCareInnovation #MedicalDevices #VisionRestoration #RetinalImplants #EyeHealth #FutureOfVision #SightSolutions #Ophthalmology #EyeSurgeryTech #SmartImplants #VisionRecovery #NextGenHealthcare #BionicEye #EyeImplantResearch #VisionInnovation #SightForAll #MedicalTech #OcularTechMarket

A recent study titled, “All enabling technology is not created equal: comparing outcomes of computer-assisted fluoroscopic navigation versus robotic-assisted total hip arthroplasty,” highlights key advantages of digital fluoroscopic navigation over robotic-assisted total hip arthroplasty. https://bit.ly/3C6CMob Hear from Dr. Jenna Bernstein, on how this first large-scale analysis using real-world data found that digital fluoroscopic navigation, like the VELYS™ Hip Navigation system, achieved shorter operating times, lower readmission rates, and lower 90-day costs compared to robotic procedures. These findings mark an important step toward making hip arthroplasty procedures more efficient for patients and healthcare providers. We are proud to offer innovative solutions like the VELYS™ Hip Navigation and remain committed to advancing orthopaedic research and development.